Cargando…

Relationship between the expression of oestrogen receptor and progesterone receptor and (18)F-FDG uptake in endometrial cancer

Background: Progestogens have been widely used for the treatment of inoperable endometrial cancer or younger patients with endometrial cancer. Identifying markers that are predictive of a response to progestogens is critical for successful therapy. Molecular imaging with (18)F(-)fluorodeoxyglucose p...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Chunhua, Chen, Ruohua, Xu, Lian, Chen, Yumei, Wang, Yining, Huang, Gan, Liu, Jianjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377875/
https://www.ncbi.nlm.nih.gov/pubmed/32639950
http://dx.doi.org/10.18632/aging.103352
_version_ 1783562300586721280
author Wu, Chunhua
Chen, Ruohua
Xu, Lian
Chen, Yumei
Wang, Yining
Huang, Gan
Liu, Jianjun
author_facet Wu, Chunhua
Chen, Ruohua
Xu, Lian
Chen, Yumei
Wang, Yining
Huang, Gan
Liu, Jianjun
author_sort Wu, Chunhua
collection PubMed
description Background: Progestogens have been widely used for the treatment of inoperable endometrial cancer or younger patients with endometrial cancer. Identifying markers that are predictive of a response to progestogens is critical for successful therapy. Molecular imaging with (18)F(-)fluorodeoxyglucose positron emission tomography ((18)F-FDG PET) can provide metabolic phenotypic information of many malignancies. We investigated whether estrogen receptor (ER)/progestogen receptor (PR) status is correlated with (18)F-FDG uptake, and whether (18)F-FDG PET/CT could be useful for predicting ER/PR status in endometrial cancer. Results: Endometrial cancers in the ER-positive group had lower SUVmax than those in the ER-negative group (12.3 ± 6.2 vs. 19.9 ± 6.6, respectively; P = 0.003). Endometrial cancers in the PR-positive group also had lower SUVmax than those in the PR-negative group (12.4 ± 6.2 vs. 20.0 ± 6.9, respectively; P = 0.005). Multivariate analysis indicated that SUVmax and tumour differentiation grade were significantly associated with both ER and PR status (P = 0.027 and P = 0.044, respectively). ER expression was predicted with an accuracy of 74.2% when a SUVmax value of 15.3 was used as a cutoff point for analysis. Similarly, PR expression was predicted with an accuracy of 74.2%, when a SUVmax value of 15.95 was used as the threshold for analysis. Conclusion: Higher (18)F-FDG accumulation in endometrial cancers is correlated with negative ER/PR expression. (18)F-FDG PET/CT may be used to predict the status of ER/PR and thus aid in optimal treatment decision in endometrial cancers. Methods: We carried out a retrospective analysis on 62 endometrial cancer patients who underwent (18)F-FDG PET/CT before radical treatment. The maximum of standardized uptake value (SUVmax) was calculated from the (18)F-FDG accumulation of the primary tumor. The relationship between SUVmax and ER/PR status was analyzed.
format Online
Article
Text
id pubmed-7377875
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Impact Journals
record_format MEDLINE/PubMed
spelling pubmed-73778752020-07-31 Relationship between the expression of oestrogen receptor and progesterone receptor and (18)F-FDG uptake in endometrial cancer Wu, Chunhua Chen, Ruohua Xu, Lian Chen, Yumei Wang, Yining Huang, Gan Liu, Jianjun Aging (Albany NY) Research Paper Background: Progestogens have been widely used for the treatment of inoperable endometrial cancer or younger patients with endometrial cancer. Identifying markers that are predictive of a response to progestogens is critical for successful therapy. Molecular imaging with (18)F(-)fluorodeoxyglucose positron emission tomography ((18)F-FDG PET) can provide metabolic phenotypic information of many malignancies. We investigated whether estrogen receptor (ER)/progestogen receptor (PR) status is correlated with (18)F-FDG uptake, and whether (18)F-FDG PET/CT could be useful for predicting ER/PR status in endometrial cancer. Results: Endometrial cancers in the ER-positive group had lower SUVmax than those in the ER-negative group (12.3 ± 6.2 vs. 19.9 ± 6.6, respectively; P = 0.003). Endometrial cancers in the PR-positive group also had lower SUVmax than those in the PR-negative group (12.4 ± 6.2 vs. 20.0 ± 6.9, respectively; P = 0.005). Multivariate analysis indicated that SUVmax and tumour differentiation grade were significantly associated with both ER and PR status (P = 0.027 and P = 0.044, respectively). ER expression was predicted with an accuracy of 74.2% when a SUVmax value of 15.3 was used as a cutoff point for analysis. Similarly, PR expression was predicted with an accuracy of 74.2%, when a SUVmax value of 15.95 was used as the threshold for analysis. Conclusion: Higher (18)F-FDG accumulation in endometrial cancers is correlated with negative ER/PR expression. (18)F-FDG PET/CT may be used to predict the status of ER/PR and thus aid in optimal treatment decision in endometrial cancers. Methods: We carried out a retrospective analysis on 62 endometrial cancer patients who underwent (18)F-FDG PET/CT before radical treatment. The maximum of standardized uptake value (SUVmax) was calculated from the (18)F-FDG accumulation of the primary tumor. The relationship between SUVmax and ER/PR status was analyzed. Impact Journals 2020-07-08 /pmc/articles/PMC7377875/ /pubmed/32639950 http://dx.doi.org/10.18632/aging.103352 Text en Copyright © 2020 Wu et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Wu, Chunhua
Chen, Ruohua
Xu, Lian
Chen, Yumei
Wang, Yining
Huang, Gan
Liu, Jianjun
Relationship between the expression of oestrogen receptor and progesterone receptor and (18)F-FDG uptake in endometrial cancer
title Relationship between the expression of oestrogen receptor and progesterone receptor and (18)F-FDG uptake in endometrial cancer
title_full Relationship between the expression of oestrogen receptor and progesterone receptor and (18)F-FDG uptake in endometrial cancer
title_fullStr Relationship between the expression of oestrogen receptor and progesterone receptor and (18)F-FDG uptake in endometrial cancer
title_full_unstemmed Relationship between the expression of oestrogen receptor and progesterone receptor and (18)F-FDG uptake in endometrial cancer
title_short Relationship between the expression of oestrogen receptor and progesterone receptor and (18)F-FDG uptake in endometrial cancer
title_sort relationship between the expression of oestrogen receptor and progesterone receptor and (18)f-fdg uptake in endometrial cancer
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377875/
https://www.ncbi.nlm.nih.gov/pubmed/32639950
http://dx.doi.org/10.18632/aging.103352
work_keys_str_mv AT wuchunhua relationshipbetweentheexpressionofoestrogenreceptorandprogesteronereceptorand18ffdguptakeinendometrialcancer
AT chenruohua relationshipbetweentheexpressionofoestrogenreceptorandprogesteronereceptorand18ffdguptakeinendometrialcancer
AT xulian relationshipbetweentheexpressionofoestrogenreceptorandprogesteronereceptorand18ffdguptakeinendometrialcancer
AT chenyumei relationshipbetweentheexpressionofoestrogenreceptorandprogesteronereceptorand18ffdguptakeinendometrialcancer
AT wangyining relationshipbetweentheexpressionofoestrogenreceptorandprogesteronereceptorand18ffdguptakeinendometrialcancer
AT huanggan relationshipbetweentheexpressionofoestrogenreceptorandprogesteronereceptorand18ffdguptakeinendometrialcancer
AT liujianjun relationshipbetweentheexpressionofoestrogenreceptorandprogesteronereceptorand18ffdguptakeinendometrialcancer